Stem cell-based products for veterinary use: specific questions on target animal safety to be addressed by the Ad Hoc Expert Group on Veterinary Novel Therapies (ADVENT)

Current version

PDF icon Problem statement

Deadline for comments: 30/09/2016

Reference numberEMA/CVMP/ADVENT/193811/2016
Published25/07/2016
Keywordsanimal stem cell -based products (ASCP), target animal safety (TAS) studies, veterinary, mesenchymal
DescriptionThis problem statement provides the basis for development of a guidance on target animal safety in relation to stem cell products intended for veterinary use. If you have any comments on the content of the document, use this. The completed comments form should be sent to vet-guidelines@ema.europa.eu.


Related content

Topics

How useful was this page?

Add your rating